Opioid Free Anesthesia-Analgesia Strategy and Surgical Stress in Elective Open Abdominal Aortic Aneurysm Repair

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age40-85
SponsorUniversity of Crete

About this trial

Open Abdominal Aortic Aneurysm (AAA) repair is a high-risk surgical procedure accompanied by intense endocrine and metabolic responses to surgical stress, with subsequent activation of the inflammatory cascade, cytokine and acute-phase protein release, and bone marrow activation. There is a proven correlation of surgical stress, which patients undergoing open AAA repair are subjected to, with patient outcome, morbidity/mortality, intensive care unit stay and overall length of stay. Modern general anesthetic techniques have been revised and rely on perioperative multimodal anesthetic and analgesic strategies for improved overall patient outcome. Based on this context of a multimodal anesthetic technique and having taken into consideration the international "opioid-crisis" epidemic, an Opioid Free Anesthesia-Analgesia (OFA-A) strategy started to emerge. It is based on the administration of a variety of anesthetic/analgesic agents with different mechanisms of action, including immunomodulating and anti-inflammatory effects.

Our basic hypothesis is that the implementation of a perioperative multimodal OFA-A strategy, involving the administration of pregabalin, ketamine, dexmedetomidine, lidocaine, dexamethasone, dexketoprofen, paracetamol and magnesium sulphate, will lead to attenuation of surgical stress response compared to a conventional Opioid-Based Anesthesia-Analgesia (OBA-A) strategy. Furthermore, the anticipated attenuation of the inflammatory response, is pressumed to be associated with equal or improved analgesia, compared to a perioperative OBA-A technique.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patient Consent

Age between 40 and 85 years old

Patients undergoing Elective Open Abdominal Aortic Infrarenal Aneurysm Repair

Disqualifiers

Immunocompromised patients

Patients with active infection

Reoperation on the aorta

Inflammatory bowel Disease

Trial design

Design model

Parallel

Treatments tested in this trial

  • Opioid-Based Anesthesia-Analgesia Strategy

    Drug

    A perioperative Opioid-Based multimodal Anesthesia-Analgesia strategy will be implemented as described in the Opioid-Based arm of the study.

  • Opioid-free Anesthesia-Analgesia Strategy

    Drug

    A perioperative Opioid-Free multimodal Anesthesia-Analgesia strategy will be implemented as described in the Opioid-Free arm of the study.

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: Opioid-Based Anesthesia AnalgesiaActive comparator 1 intervention
Group B: Opioid-Free Anesthesia AnalgesiaActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Surgical Stress Response - IL-6 - Preoperatively

Inflammatory response and stress response as quantified by IL-6 serum levels. Blood sample collection will take place in both study groups.

Time frame
1) Preoperatively (as a baseline)
2

Surgical Stress Response - IL-6 - 15 minutes after aortic cross-clamp

Inflammatory response and stress response as quantified by IL-6 serum levels. Blood sample collection will take place in both study groups.

Time frame
2) 15 minutes after aortic cross-clamping
3

Surgical Stress Response - IL-6 - 60 minutes after aortic cross-clamp

Inflammatory response and stress response as quantified by IL-6 serum levels. Blood sample collection will take place in both study groups.

Time frame
3) 60 minutes after aortic cross-clamp release
4

Surgical Stress Response - IL-6 - 24 hours after aortic cross-clamp release

Inflammatory response and stress response as quantified by IL-6 serum levels. Blood sample collection will take place in both study groups.

Time frame
4) 24 hours after aortic cross-clamp release

Secondary outcomes

1

Postoperative pain - Numerical Rating Scale (NRS) - Immediately Postoperatively

Evaluation of patients' pain using scales: Numerical Rating Scale (NRS). The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable").

Time frame
1) Immediately postoperatively (if awakened prior to ICU admission)
2

Postoperative pain - Numerical Rating Scale (NRS) - First postoperative day

Evaluation of patients' pain using scales: Numerical Rating Scale (NRS). The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable").

Time frame
2) First postoperative day
3

Postoperative pain - Numerical Rating Scale (NRS) - Second postoperative day

Evaluation of patients' pain using scales: Numerical Rating Scale (NRS). The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable").

Time frame
3) Second postoperative day
4

Postoperative pain - Numerical Rating Scale (NRS) - Third postoperative day

Evaluation of patients' pain using scales: Numerical Rating Scale (NRS). The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable").

Time frame
4) Third postoperative day

Other outcomes

1

Haemodynamic Stability - Coefficient of Variation PR

Haemodynamic Stability as quantified by hemodynamic markers, specifically Pulse Rate - PR. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. The Coefficient of variation of the PR values will be reported for each patient, extracted from the collected data.

Time frame
Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
2

Haemodynamic Stability - Average Real Variability PR

Haemodynamic Stability as quantified by hemodynamic markers, specifically Average Real Variability of the PR. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Values will be averaged every minute and the Average Real Variability will be reported for each patient, extracted from the collected data.

Time frame
Every minute from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
3

Haemodynamic Stability - Coefficient of Variation SBP

Haemodynamic Stability as quantified by hemodynamic markers, specifically Systolic Blood Pressure - SBP. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. The Coefficient of variation of SBP values will be reported for each patient, extracted from the collected data.

Time frame
Every 20 seconds from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.
4

Haemodynamic Stability - Average Real Variability SBP

Haemodynamic Stability as quantified by hemodynamic markers, specifically Average Real Variability of the SBP. Data will be collected from a pulse contour analysis monitor, and values will be collected every 20 seconds. Values will be averaged every minute and the Average Real Variability will be reported for each patient, extracted from the collected data.

Time frame
Every minute from anesthesia induction, until the end of surgery (end of placement of last suture/surgical clip on patient), assessed up to 8 hours.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Crete

Lead sponsor

University Hospital of Crete

Collaborator